United States · FDA National Drug Code directory
Dantrolene
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9297_769b1f03-2d55-42b7-b29d-60fb5275a67f
- Product NDC
- 0143-9297
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Dantrolene
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170619
- Source listing expiry
- 20261231
Source-listed ingredients
- DANTROLENE SODIUM — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9297-01) · 0143-9297-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →